IBDEI2GJ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41677,1,4,0)
 ;;=4^K71.7
 ;;^UTILITY(U,$J,358.3,41677,2)
 ;;=^5008802
 ;;^UTILITY(U,$J,358.3,41678,0)
 ;;=K71.8^^159^2007^33
 ;;^UTILITY(U,$J,358.3,41678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41678,1,3,0)
 ;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
 ;;^UTILITY(U,$J,358.3,41678,1,4,0)
 ;;=4^K71.8
 ;;^UTILITY(U,$J,358.3,41678,2)
 ;;=^5008803
 ;;^UTILITY(U,$J,358.3,41679,0)
 ;;=K71.9^^159^2007^34
 ;;^UTILITY(U,$J,358.3,41679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41679,1,3,0)
 ;;=3^Toxic Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41679,1,4,0)
 ;;=4^K71.9
 ;;^UTILITY(U,$J,358.3,41679,2)
 ;;=^5008804
 ;;^UTILITY(U,$J,358.3,41680,0)
 ;;=K75.2^^159^2007^20
 ;;^UTILITY(U,$J,358.3,41680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41680,1,3,0)
 ;;=3^Nonspecific Reactive Hepatitis
 ;;^UTILITY(U,$J,358.3,41680,1,4,0)
 ;;=4^K75.2
 ;;^UTILITY(U,$J,358.3,41680,2)
 ;;=^5008826
 ;;^UTILITY(U,$J,358.3,41681,0)
 ;;=K75.3^^159^2007^13
 ;;^UTILITY(U,$J,358.3,41681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41681,1,3,0)
 ;;=3^Granulomatous Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,41681,1,4,0)
 ;;=4^K75.3
 ;;^UTILITY(U,$J,358.3,41681,2)
 ;;=^5008827
 ;;^UTILITY(U,$J,358.3,41682,0)
 ;;=K76.6^^159^2007^22
 ;;^UTILITY(U,$J,358.3,41682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41682,1,3,0)
 ;;=3^Portal Hypertension
 ;;^UTILITY(U,$J,358.3,41682,1,4,0)
 ;;=4^K76.6
 ;;^UTILITY(U,$J,358.3,41682,2)
 ;;=^5008834
 ;;^UTILITY(U,$J,358.3,41683,0)
 ;;=F20.3^^159^2008^25
 ;;^UTILITY(U,$J,358.3,41683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41683,1,3,0)
 ;;=3^Undifferentiated/Atypical Schizophrenia
 ;;^UTILITY(U,$J,358.3,41683,1,4,0)
 ;;=4^F20.3
 ;;^UTILITY(U,$J,358.3,41683,2)
 ;;=^5003472
 ;;^UTILITY(U,$J,358.3,41684,0)
 ;;=F20.9^^159^2008^21
 ;;^UTILITY(U,$J,358.3,41684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41684,1,3,0)
 ;;=3^Schizophrenia,Unspec
 ;;^UTILITY(U,$J,358.3,41684,1,4,0)
 ;;=4^F20.9
 ;;^UTILITY(U,$J,358.3,41684,2)
 ;;=^5003476
 ;;^UTILITY(U,$J,358.3,41685,0)
 ;;=F31.9^^159^2008^6
 ;;^UTILITY(U,$J,358.3,41685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41685,1,3,0)
 ;;=3^Bipolar Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,41685,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,41685,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,41686,0)
 ;;=F31.72^^159^2008^7
 ;;^UTILITY(U,$J,358.3,41686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41686,1,3,0)
 ;;=3^Bipolr Disorder,Full Remis,Most Recent Episode Hypomanic
 ;;^UTILITY(U,$J,358.3,41686,1,4,0)
 ;;=4^F31.72
 ;;^UTILITY(U,$J,358.3,41686,2)
 ;;=^5003512
 ;;^UTILITY(U,$J,358.3,41687,0)
 ;;=F31.71^^159^2008^5
 ;;^UTILITY(U,$J,358.3,41687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41687,1,3,0)
 ;;=3^Bipolar Disorder,Part Remis,Most Recent Episode Hypomanic
 ;;^UTILITY(U,$J,358.3,41687,1,4,0)
 ;;=4^F31.71
 ;;^UTILITY(U,$J,358.3,41687,2)
 ;;=^5003511
 ;;^UTILITY(U,$J,358.3,41688,0)
 ;;=F31.70^^159^2008^4
 ;;^UTILITY(U,$J,358.3,41688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41688,1,3,0)
 ;;=3^Bipolar Disorder,In Remis,Most Recent Episode Unspec
 ;;^UTILITY(U,$J,358.3,41688,1,4,0)
 ;;=4^F31.70
 ;;^UTILITY(U,$J,358.3,41688,2)
 ;;=^5003510
 ;;^UTILITY(U,$J,358.3,41689,0)
 ;;=F29.^^159^2008^19
 ;;^UTILITY(U,$J,358.3,41689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41689,1,3,0)
 ;;=3^Psychosis not d/t Substance/Known Physiol Cond,Unspec
 ;;^UTILITY(U,$J,358.3,41689,1,4,0)
 ;;=4^F29.
 ;;^UTILITY(U,$J,358.3,41689,2)
 ;;=^5003484
 ;;^UTILITY(U,$J,358.3,41690,0)
 ;;=F28.^^159^2008^20
 ;;^UTILITY(U,$J,358.3,41690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41690,1,3,0)
 ;;=3^Psychosis not d/t Substance/Known Physiol Cond NEC
